Противопаразитарные Препараты

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas Pharma to acquire Propella Therapeutic...

Astellas Pharma EMEA celebrates its 10th annive...

FDA Grants Full Approval for Astellas Pharma's ...

Astellas Pharma

Astellas Pharma - Global Web Site on Behance

Astellas Pharma Inc. (4503N.MX) stock price, ne...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas Pharma Joins Record Bond Sales by Japa...

Astellas

Astellas Pharmaceuticals Establishes Open Innov...

Astellas Offloads 5 Legacy Products to Germany’...

Japan's Astellas sees cancer drug fueling 29% p...

Атлас лекарственных растений - YouTube

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

About | Astellas Pharma Ltd

Asia Business Daily on Twitter: "Astellas Pharm...

China Formally Arrests Japanese Employee of Dru...

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharma: A Contrarian Investment (OTCMK...

Pharmaceutical Technology

Главная | Astellas Pharma Russia

Astellas Home page | Astellas Pharma Inc.

Главная | Astellas Pharma Russia

Astellas, University of Tokyo extend partnershi...

Astellas introduces sustainable community initi...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Home | Astellas Pharma Canada, Inc.

Astellas' Prostate Cancer Drug Available In Jap...

Astellas gets FDA priority review for gastric c...

FDA Approves Astellas’ Non-hormonal Menopause T...

US FDA approves Astellas Pharma pill for menopa...

Astellas Home page | Astellas Pharma Inc.

Astellas Sues Over New Myrbetriq Patent to Reca...